Drug Clinical Trials List
Drug Clinical Trials List
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Effect of subcutaneous semaglutide 2.4 mg once-weekly compared to placebo in subjects with obesity and knee osteoarthritis | Novo Nordisk | Ongoing | semaglutide | 3 | NN9536-4578 | King Fahad Medical City (Riyadh) |
| Effect of Preoperative Administration of Ibuprofen in Children Undergoing Extraction for Reducing Postoperative Pain: A Double-blind Randomized Controlled Clinical Trial | Princess Nourah University | Completed | ibuprofen | 3 | 18-0253 | PNU-CD |
| Effect of Gum Arabic supplementation on butyrate, uremic retention molecules and inflammation in chronic kidney disease patients | King Fahad Specialist Hospital - Dammam / KACST | Completed | Gum Arabic / E-114 | 2 | 2 | KFSH |
| Early administration of Tocilizumab in Immunocompromised and potential high-risk patients for developing COVID-19 | King Faisal Specialist Hospital & Research Centre | Completed | TOCILIZUMAB | 2 | 2201070 | KFSH&RC-R |
| Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG) | KKUH | Ongoing | Heparin - Enoxaparin - Tinzaparin - Fondaparinux | 3 | 1.2 | King Khalid University Hospital (Riyadh) |
| "Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic ( RAPID COVID COAG) " | KAIMRC | Completed | TINZAPARIN SODIUM | 3 | RC20/403 | King Abdulaziz Medical City NG (Riyadh) |
| Circulating Endotoxin as a Contributing Inflammatory Mediator in Osteoporosis Risk and its Association with Vitamin D Deficiency | National Plan for Science and Technology | Ongoing | Vitamin D3 VS. Alendronate | 3 | 11-MED-2113-02 or (G1109-665) | KFMC |
| Cholecalciferol supplementation in critically ill patients with severe vitamin D deficiency in intensive care unit – a randomized controlled trial | King Abdullah Medical City, Makkah | Ongoing | VITAMIN D3 (CHOLECALCIFEROL) | 3 | IRB#16-252, V2 | KAMC |
| Bi-weekly Cetuximab and XELIRI(Capecitabine and Irinotecan) as first line therapy in K/N-RAS wild type advanced colorectal cancer: Phase I-II CETUXIRI study | King Faisal Specialist Hospital and Research Centre | Completed | Cetuximab | 1/2 | 1 , 29/07/2015 | KFSH&RC-R |
| Autologous Bone marrow derived osteoblasts in the Management of Avascular Necrosis of the Head of Femur: A Phase II | PI initiated | Rejected | Osteoblasts Stem cells | 2 | 2018-01-315 | King Fahad University Hospital (Al-Khobar) |